Results 161 to 170 of about 68,908 (269)

Successful Treatment of Oxaliplatin‐Induced Immune Thrombocytopenia in a Schizophrenic Patient With Contraindication to Steroids Using Cyclosporine Plus Eltrombopag: A Case Report

open access: yesCase Reports in Medicine, Volume 2026, Issue 1, 2026.
Background Oxaliplatin is widely used in the treatment of gastrointestinal tumors but is associated with rare adverse effects, including immune thrombocytopenia. The incidence of oxaliplatin‐associated immune thrombocytopenia (OIIT) may be frequently overlooked due to its rarity, and in some cases, it can be difficult to treat.
Jian Zheng   +5 more
wiley   +1 more source

Antipsychotic medication for people with first episode schizophrenia: an exploratory economic analysis of alternative treatment algorithms [PDF]

open access: yes
Available clinical evidence suggests that the newer antipsychotics are similar to conventional antipsychotics for positive symptom control. It has been suggested that they may also be superior for negative symptoms and side effects, but the evidence for ...
Linda Davies, Shon Lewis
core  

Adjunctive Treatment of Acute Mania with Risperidone versus Typical Antipsychotics: A Retrospective Study [PDF]

open access: gold, 2005
Jui‐Hsiu Tsai   +6 more
openalex   +1 more source

Successful Clozapine Rechallenge in a 40‐Year‐Old Male Patient With Paranoid Schizophrenia After Clozapine‐Associated Myocarditis

open access: yesCase Reports in Psychiatry, Volume 2026, Issue 1, 2026.
Background Clozapine‐associated myocarditis (CAM) is the most common inflammatory adverse effect under clozapine treatment. In the absence of equally effective therapeutic alternatives for treating treatment‐resistant schizophrenia (TRS), clinicians are often faced with the question of whether to rechallenge clozapine in patients who have experienced ...
Lukas Zabel   +6 more
wiley   +1 more source

Nuances of Gender Identity for a Transgender Patient Receiving Inpatient Treatment for Paranoid Schizophrenia: A Case Study

open access: yesCase Reports in Psychiatry, Volume 2026, Issue 1, 2026.
Introduction Nearly one‐fourth of individuals diagnosed with schizophrenia may experience symptoms of gender dysphoria. Patients may identify with a gender other than the gender assigned at birth before or after psychotic disorder onset. In either case, the presence of both psychosis and gender dysphoria may complicate evaluation and treatment. Case We
Ravleen Kaur Suri   +4 more
wiley   +1 more source

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia

open access: yesNeuropsychiatric Disease and Treatment, 2011
Hongyan Zhang1, Huafang Li2, Liang Shu1, Niufan Gu2, Gang Wang3, Yongzhen Weng3, Shiping Xie4, Xinbao Zhang4, Ting Li5, Cui Ma5, Wei Yu6, Bruce Parsons7, Manjula Schou81Institute of Mental Health, Peking University, Beijing, China; 2Shanghai Mental ...
Hongyan Zhang   +3 more
doaj  

Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study

open access: hybrid, 2021
Yuriy Filts   +5 more
openalex   +1 more source

Effectiveness of Electroconvulsive Therapy in the Remission of Malignant Catatonia Associated With Schizophrenia: A Case Report

open access: yesCase Reports in Psychiatry, Volume 2026, Issue 1, 2026.
Despite the robust body of evidence supporting the efficacy and safety of electroconvulsive therapy (ECT) in the treatment of severe psychiatric disorders, this procedure remains at the center of social debate, often influenced by historical prejudice.
Lucas Reis Alves Mota   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy